Search results
Sep 29, 2023 · Joe Arron and Mark Eisner worked together for about a decade at Genentech, with broad remits but a shared passion for interstitial lung disease. They’d go their separate ways a few years ago — Arron to 23andMe as chief scientific officer of its therapeutics push and Eisner to FibroGen, where he led the medical operations.
May 29, 2024 · SAN FRANCISCO, May 29, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Mark D. Eisner, M.D., M.P.H. will join the company as Executive Vice President and Chief Medical...
Mark Eisner, M.D., M.P.H., has served as Vir’s Executive Vice President and Chief Medical Officer (CMO) since June of 2024. Dr. Eisner is responsible for leading Translational and Clinical Development, including Clinical Research, Development Operations, Biometrics, Clinical Pharmacology, Pharmacovigilance, and Risk Management, as well as ...
May 4, 2022 · If sold for $225 million, the home will break sale records in California, which was set last year when billionaire Silicon Valley venture capitalist Marc Andreessen shelled out $177 million for a...
Jun 10, 2024 · One of our newest executive management team members, Mark Eisner, brings a wealth of experience and expertise that will support Vir as we enter our next phase of clinical and regulatory...
Apr 19, 2023 · Let’s break down the three key animal areas Eisner highlighted in his speech — “real, ancient, and imagined” — and explore how they applied to guests’ experiences at the park in 1998 and still...
People also ask
What animal areas did Eisner highlight in his speech?
Who is Dr Eisner & what does he do at Genentech?
What degree does Dr Eisner have?
View Mark Eisner’s profile on LinkedIn, a professional community of 1 billion members. Experience: Vir Biotechnology, Inc. · Education: Stanford University · Location: San Francisco Bay Area...
- Vir Biotechnology, Inc.
